Aventi GI Complete Tablets:
AVENTI GI COMPLETE CHEWABLE TABLETS
Aventix
Maintains a healthy immune system in the bowel
Supplies nutrients to the gastrointestinal tract
Maintains a water and electrolytes balance
Encourages a healthy intestinal flora
Ingredients per chewable tablet:
Actives: fructooligosaccharides (FOS) 480 mg, mannane-oligosaccharides (MOS) 48.60 mg, Lactobacillus acidophilus 24 mg (7.2 billion CFU), Lactobacillus plantarum 24 mg (2.4 billion CFU), Enterococcus faecium 0.01 mg (42,000 CFU), Lactobacillus rhamnosus (NCIMB 30121) 0.01 mg (24,000 CFU), Lactobacillus brevis (DSM12835) 0.01 mg (24,000 CFU), Lactobacillus buchneri (DSM12856) 0.01 mg (24,000 CFU), Pediococcus pentosaceus (DSM12834) 0.01 mg (24,000 CFU), fermentation products from Lactococcus lactis 0.22 mg, whey protein hydrolysate 0.22 mg, Saccharomyces cerevisiae 99.60 mg, ruptured cells of Saccharomyces cerevisiae (nucleotides) 1.20 mg, sodium chloride 1.92 mg, potassium sulfate 1.92 mg, magnesium oxide 0.40 mg, dibasic calcium phosphate 1.76 mg, niacinamide (vit PP) 23.04 mg, thiamine (vit B1) 3.00 mg, riboflavin (vit B2) 0.96 mg, pyridoxine (vit B6) 0.96 mg
Inactives: microcrystalline cellulose, lecithin, magnesium stearate, silicon dioxide, vegetable cellulose, vegetable protein, vegetable oil, vegetable fat, brewer's yeast, proprietary palatability enhancer.
Posology: To be administered orally for 1 to 2 weeks or as directed by your veterinarian. Daily quantity can be divided between am & pm.
Species/weight
Daily quantity
Cats
1 tablet
Dogs
0-7 kg (0-15 lbs)
1 tablet
7-14 kg (15-30 lbs)
2 tablets
14-21 kg (30-45 lbs)
3 tablets
21-35 kg (45-75 lbs)
4 tablets
> 35 kg (> 75 lbs)
5-6 tablets
Warnings: Keep out of reach of children.
Storage: Do not remove tabs from packaging until ready to use. Store in a dry place, away from direct sunlight.
Id N�: αIT000194TO
Manufactured in Italy by: ACEL pharma S.r.l. - via A. Manzoni 2, 10092 Beinasco (TO)
Formerly: Candioli Pharma
[email protected]
Distributor: AVENTIX, Burlington, Ontario, Canada, L7L 5R7
For questions or side effect report: 1-877-909-2242
Quality Statement
ACEL pharma is annually inspected by Certiquality, in accordance with the safety requirements set by the US Code of Federal Regulations (title 21, volume 2, part 111, from May 1st, 2017) for the manufacturing activity of dietary supplements for pets. The Quality Management System of the company is in compliance with the standard UNI EN ISO 9001:2015.
Net
120 CHEWABLE TABLETS
5.08 oz. e
CO3255V0
CPN: 1378027.0
SDS:
AVENTI GI COMPLETE TABLETS
Code SLP2765
SAFETY DATA SHEET
Revision 1
Date of revision 31/03/2019
Page 1 / 9
SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING
1.1. PRODUCT IDENTIFIER
Product name: AVENTI GI COMPLETE TABLETS
EC No.: Not applicable
CAS No.: Not applicable
REACH Registration N�.: Not applicable
1.2. RELEVANT IDENTIFIED USES OF THE SUBSTANCE OR MIXTURE AND USES ADVISED AGAINST
1.2.1. Relevant identified uses
Feed supplement
1.2.2. Uses advised against
No particular information
1.3. DETAILS OF THE SUPPLIER OF THE SAFETY DATA SHEET
1.3.1. Supplier
Manufacturer/Supplier: ACEL PHARMA S.r.l. u.s.
Address: Via A. Manzoni, 2 10092 Beinasco (TO)
Phone and fax numbers: 0039 011 3490232
e-mail address of competent person responsible for the SDS: [email protected]
1.3.2. Importer/Only representative
Manufacturer/Supplier: ACEL PHARMA S.r.l. u.s.
Via Manzoni, 2 10092 Beinasco (TO)
1.4. EMERGENCY TELEPHONE NUMBER
References to emergency information services:
Supplier: +39.011.34.90.232
CAV c/o Azienda Sanitaria Ospedaliera S.Giovanni Battista Ospedale "Molinette": +39 011 6637637
Centro Antiveleni (Milano Niguarda): +39 02 66101029
Centro Antiveleni (Roma): +39 06 3054343
SECTION 2: HAZARDS IDENTIFICATION
2.1. CLASSIFICATION OF THE SUBSTANCE OR MIXTURE
2.1.1. Classification according to Regulation (EC) No 1272/2008 (CLP)
CLASS CODES AND HAZARD STATEMENTS:
Aquatic Chronic 4 - H413
2.1.2. Additional information
For full text of Hazard- and EU Hazard-statements: see SECTION 16.
2.2. LABEL ELEMENTS
2.2.1. Labelling according to Regulation (EC) No 1272/2008 (CLP)
HAZARD PICTOGRAMS:
--
SIGNAL WORD:
--
HAZARD STATEMENTS:
H413: May cause long lasting harmful effects to aquatic life.
PRECAUTIONARY STATEMENTS:
--
2.3. OTHER HAZARDS
2.3.1. Adverse physicochemical effects
Information not available
2.3.2. Adverse human health effects and symptoms
AVENTI GI COMPLETE TABLETS
Code SLP2765
SAFETY DATA SHEET
Revision 1
Date of revision 31/03/2019
Page 2 / 9
Information not available
When used properly, the product is safe and tolerable in accordance with the legal provisions (Article 3 of the EC Cosmetics Regulation). Any
other hazard information applies to inadvertent misuse or accidents.
2.3.3. Adverse environmental effects
Information not available
When used properly, the product is safe and tolerable in accordance with the legal provisions (Article 3 of the EC Cosmetics Regulation). Any
other hazard information applies to inadvertent misuse or accidents.
2.3.4. Other adverse hazards
Information not available
SECTION 3: COMPOSITION/INFORMATION ON INGREDIENTS
3.1. SUBSTANCES
3.2. MIXTURES
The mixture contain the following substances presenting a health or environmental hazard within the meaning of Regulation (EC)
No 1272/2008.
MAGNESIUM STEARATE; CAS# 557-04-0; [0,1 - 1%]
Class codes: Aquatic Chronic 4
Hazard statements: H250; H315; H319; H335; H372; H373; H413
SECTION 4: FIRST AID MEASURES
4.1. DESCRIPTION OF FIRST AID MEASURES
4.1.1. General notes
When the contact with the product, use or handling, causes symptoms requiring a prompt aid, follow the directives below for the specifical
exposure route.
4.1.2. Following inhalation
In case of inhalation, affected person should be moved into fresh air and kept still. If breathing is difficult consult a doctor.
4.1.3. Following skin contact
Remove contaminated, saturated clothing immediately. Wash thoroughly the body (shower or bath). When in doubt or if symptoms are
observed, get medical advice.
4.1.4. Following eye contact
Remove contact lenses. After contact with the eyes, rinse with water with the eyelids open for a sufficient length of time, then consult an
ophthalmologist immediately.
4.1.5. Following ingestion
If accidentally swallowed rinse the mouth with plenty of water (only if the person is conscious) and obtain immediate medical attention. Do not
induce vomiting when the affected person is unconscious.
4.1.6. Self-protection of the first aider
No particular information
4.2. MOST IMPORTANT SYMPTOMS AND EFFECTS, BOTH ACUTE AND DELAYED
4.2.1. Symptoms
See Section 11 (Toxicological information)
4.2.2. Effects
See Section 11 (Toxicological information)
4.3. INDICATION OF ANY IMMEDIATE MEDICAL ATTENTION AND SPECIAL TREATMENT NEEDED
4.3.1. Notes for the doctor
Information not available
4.3.2. Special treatment
Information not available
SECTION 5: FIREFIGHTING MEASURES
5.1. EXTINGUISHING MEDIA
5.1.1. Suitable extinguishing media
Carbon dioxide, foam, powder, water mist.
AVENTI GI COMPLETE TABLETS
Code SLP2765
SAFETY DATA SHEET
Revision 1
Date of revision 31/03/2019
Page 3 / 9
5.1.2. Unsuitable extinguishing media
No particular media.
5.2. SPECIAL HAZARDS ARISING FROM THE SUBSTANCE OR MIXTURE
5.2.1. Hazardous combustion products
However avoid breathing combustion products.
5.3. ADVICE FOR FIREFIGHTERS
5.3.1. Advice for firefighters
Cool containers with water to avoid possible decomposition of the product and formation of potential hazardous substances.
Wear full protecting equipment available.
When possible collect estinguishing water and avoid contamination of surface waters or drains.
SECTION 6: ACCIDENTAL RELEASE MEASURES
6.1. PERSONAL PRECAUTIONS, PROTECTIVE EQUIPMENT AND EMERGENCY PROCEDURES
6.1.1. For non-emergency personnel
Wear suitable protection equipment (see also Section 8 of the SDS) to avoid inhalation, contact with the skin and eyes and contamination of
clothes.
6.1.2. For emergency responders
Wear suitable protection equipment (see also Section 8 of the SDS) to avoid inhalation, contact with the skin and eyes and contamination of
clothes.
6.2. ENVIRONMENTAL PRECAUTIONS
6.2.1. Environmental precautions
Do not allow to enter into surface water or drains.
6.3. METHODS AND MATERIAL FOR CONTAINMENT AND CLEANING UP
6.3.1. For containment
Collect product with mechanical devices (if product is flammable use only antistatically equipped spark-free tools) and store in suitable
containers for disposal. Check compatibility of the containers to collect product (see also Section 10 of the SDS).
6.3.2. For cleaning up
Use inert absorbent material (sand, vermiculite, diatomeous earth, etc.) to soak up leaked product. Collect the majority of the remaining
material and store in suitable containers for disposal. Make sure the leakage site is well aired. Contaminated material should be disposed in
compliance with the provisions of Section 13.
6.3.3. Other information
No particular information
6.4. REFERENCE TO OTHER SECTIONS
6.4.1. Reference to other sections
Safe handling: see section 7
Disposal: see section 13
Personal protection equipment: see section 8
SECTION 7: HANDLING AND STORAGE
7.1. PRECAUTIONS FOR SAFE HANDLING
7.1.1. General protective measures
Handle product after consultation of all other sections of this SDS. Avoid product dispersion. When using do not eat, drink, smoke, sniff. Avoid
improper contact with skin and eyes and inhalation.
7.1.2. Measures to prevent fire
If product is flammable provide adequate earthing of containers, equipment, pumps and ventilation facilities.
7.1.3. Measures to prevent aerosol and dust generation
No particular information
7.1.4. Measures to protect the environment
Avoid product dispersion, keep containers well closed.
7.1.5. Advice on general occupational hygiene
AVENTI GI COMPLETE TABLETS
Code SLP2765
SAFETY DATA SHEET
Revision 1
Date of revision 31/03/2019
Page 4 / 9
When using do not eat, drink, smoke, sniff. Remove clothes when contaminated. Wash hands before breaks and after work.
7.2. CONDITIONS FOR SAFE STORAGE, INCLUDING ANY INCOMPATIBILITIES
7.2.1. Technical measures and storage conditions
Store in a fresh place, not under direct sunlight and, if product is flammable, keep away from fire and sources of ignition.
7.2.2. Packaging materials
Store in original containers; after use replace the closing cap. If product is moved to other containers, label them the same way as the original
packages.
7.2.3. Requirements for storage rooms and vessels
Store in well aired and fresh place. If product is flammable, keep away from fire and sources of ignition. If incompatible materials are listed in
Section 10 of this SDS, keep them far from this product.
7.3. SPECIFIC END USE(S)
7.3.1. Recommendations
No particular information
7.3.2. Industrial sector specific solutions
No particular information
SECTION 8: EXPOSURE CONTROLS/PERSONAL PROTECTION
8.1. CONTROL PARAMETERS
8.1.1. Occupational exposure limits
Information not available
8.1.2. Biological limit values
Information not available
8.1.3. Exposure limits at intended use
Information not available
8.1.4. DNEL/PNEC-values
Information not available
8.1.5. Risk management measures according to used control banding approach
Information not available
8.2. EXPOSURE CONTROLS
8.2.1. Appropriate engineering controls
Usual measures for handling of chemical products are sufficient. Remind that proper technical measures for exposure controls should prevail
on the adoption of personal protecting equipment.
8.2.2. Personal protection equipment
The mixture must be handled in a well-ventilated place.
Skin protection: Wear appropriate protective clothing.
Hand protection: Wear appropriate protective gloves.
Eye protection: Wear opaque eye protection
8.2.3. Environmental exposure controls
Adopt all possible procedures to avoid contamination of the environment with the product.
SECTION 9: PHYSICAL AND CHEMICAL PROPERTIES
9.1. INFORMATION ON BASIC PHYSICAL AND CHEMICAL PROPERTIES
Physical state: Round beige tablet with sweetish taste and characteristic smell of vitamins
Colour: beige
Odour: characteristic
AVENTI GI COMPLETE TABLETS
Code SLP2765
SAFETY DATA SHEET
Revision 1
Date of revision 31/03/2019
Page 5 / 9
Odour threshold: Not available
pH: 6,00 � 1,00
Humidity: ≤ 4,8 %
Crude protides (N x 6,25): 4,00% - 8,00%
Crude oil and fats: 4,00% - 10,00%
Crude ash: 1,00% - 4,00%
Crude fibre: 23,5 % - 30,50%
Hardness: 40 N- 80 N
Friability: ≤ 1%
Upper flammability: Not available
Lower flammability: Not available
Upper explosivity: Not available
Lower explosivity: Not available
Vapour pressure: Not available
Vapour density: Not available
Relative density: Not available
Solubility(ies): Not available
Partition coefficient: n-octanol/water: Not available
Auto-ignition temperature: Not available
Decomposition temperature: Not available
Viscosity: Not available
Explosive properties: Not available
Oxidising properties: Not available
9.2. OTHER INFORMATION
No particular information
SECTION 10: STABILITY AND REACTIVITY
10.1. REACTIVITY
No particular reaction hazards with other chemicals at normal use and storage conditions.
10.2. CHEMICAL STABILITY
The product is stable under normal use and storage conditions.
10.3. POSSIBILITY OF HAZARDOUS REACTIONS
No hazardous reactions predictable at normal use and storage conditions.
10.4. CONDITIONS TO AVOID
No particular measures: follow however the basic measures for chemical products.
10.5. INCOMPATIBLE MATERIALS
Information not available
10.6. HAZARDOUS DECOMPOSITION PRODUCTS
Information not available
SECTION 11: TOXICOLOGICAL INFORMATION
11.1. INFORMATION ON TOXICOLOGICAL EFFECTS
11.1.1. Acute toxicity
Specifical information are not available for the mixture itself; see however Section 2 of the SDS for the identification and description of hazards
of its components.
11.1.2. Skin corrosion/irritation
AVENTI GI COMPLETE TABLETS
Code SLP2765
SAFETY DATA SHEET
Revision 1
Date of revision 31/03/2019
Page 6 / 9
Specifical information are not available for the mixture itself; see however Section 2 of the SDS for the identification and description of hazards
of its components.
11.1.3. Serious eye damage/irritation
Specifical information are not available for the mixture itself; see however Section 2 of the SDS for the identification and description of hazards
of its components.
11.1.4. Respiratory or skin sensitisation
Specifical information are not available for the mixture itself; see however Section 2 of the SDS for the identification and description of hazards
of its components.
11.1.5. Germ cell mutagenicity
Specifical information are not available for the mixture itself; see however Section 2 of the SDS for the identification and description of hazards
of its components.
11.1.6. Carcinogenicity
Specifical information are not available for the mixture itself; see however Section 2 of the SDS for the identification and description of hazards
of its components.
11.1.7. Reproductive toxicity
Specifical information are not available for the mixture itself; see however Section 2 of the SDS for the identification and description of hazards
of its components.
11.1.8. Summary of evaluation of the CMR properties
Specifical information are not available for the mixture itself; see however Section 2 of the SDS for the identification and description of hazards
of its components.
11.1.9. STOT-single exposure
Specifical information are not available for the mixture itself; see however Section 2 of the SDS for the identification and description of hazards
of its components.
11.1.10. STOT-repeated exposure
Specifical information are not available for the mixture itself; see however Section 2 of the SDS for the identification and description of hazards
of its components.
11.1.11. Aspiration hazard
Specifical information are not available for the mixture itself; see however Section 2 of the SDS for the identification and description of hazards
of its components.
SECTION 12: ECOLOGICAL INFORMATION
Use product following good working practice. Take measures to prevent the release of the substance or mixture to the environment, such as
avoiding spills or keeping away from drains.
12.1. TOXICITY
12.1.1. Acute (short-term) toxicity
Information not available
12.1.2. Chronic (long-term) toxicity
Information not available
12.2. PERSISTENCE AND DEGRADABILITY
12.2.1. Abiotic degradation
Information not available
12.2.2. Physical- and photo-chemical elimination
Information not available
12.2.3. Biodegradation
Information not available
12.3. BIOACCUMULATIVE POTENTIAL
12.3.1. Partition coefficient n-octanol/water (log Kow)
Information not available
12.3.2. Bioconcentration factor (BCF)
Information not available
12.4. MOBILITY IN SOIL
AVENTI GI COMPLETE TABLETS
Code SLP2765
SAFETY DATA SHEET
Revision 1
Date of revision 31/03/2019
Page 7 / 9
12.4.1. Known or predicted distribution to environmental compartments
Information not available
12.4.2. Surface tension
Information not available
12.4.3. Adsorption/Desorption
Information not available
12.5. RESULTS OF PBT AND VPVB ASSESSMENT
Information not available
12.6. OTHER ADVERSE EFFECTS
Information not available
12.7. ADDITIONAL INFORMATION
Information not available
SECTION 13: DISPOSAL CONSIDERATIONS
13.1. WASTE TREATMENT METHODS
13.1.1. Product/Packaging disposal
Reuse when possible. Disposal must be performed by an authorised waste management company, in compliance with current national and
local regulations. Contaminated packages must be delivered for reuse or disposal by an authorised waste management company.
13.1.2. Waste treatment-relevant information
Waste treatment must be generally performed by an authorised waste management company, in compliance with current national and local
regulations.
13.1.3. Sewage disposal-relevant information
Waste disposal must be generally performed by an authorised waste management company, in compliance with current national and local
regulations.
13.1.4. Other disposal recommendations
No particular information
SECTION 14: TRANSPORT INFORMATION
For cosmetic products that can be classified as hazardous (i.e.: flammable perfumes, aerosol products, hair dyeing products, depilatories,
etc.) the transport must be performed by authorised companies, following the provisions of ADR (carriage by road), RID (rail transport), IMO
(maritime), ICAO/IATA (air transport).
In these cases the product must be transported in suitable containers, made of material compatible with their content. Personnel must also be
trained to a level directly commensurate with their duties and responsibilities under the requirements of the regulations concerning the
carriage of dangerous goods.
14.1. ROAD OR RAIL TRANSPORT
UN Number: Not applicable
ADR/RID Class: Not applicable
Packing Group: --
Label: --
Nr. Kemler: --
Limited Quantity: --
Tunnel restriction code: --
UN proper shipping name: --
14.2. SEA TRANSPORT
UN Number: Not applicable
IMO Class: Not applicable
Packing Group: --
Label: --
EMS: --
AVENTI GI COMPLETE TABLETS
Code SLP2765
SAFETY DATA SHEET
Revision 1
Date of revision 31/03/2019
Page 8 / 9
Marine pollutant: --
UN proper shipping name: --
14.3. AIR TRANSPORT
UN Number: Not applicable
IATA: Not applicable
Packing Group: --
Label: --
Cargo: --
Packaging instructions: --
Pass: --
Special instrictions: --
UN proper shipping name: --
SECTION 15: REGULATORY INFORMATION
15.1. SAFETY, HEALTH AND ENVIRONMENTAL REGULATIONS/LEGISLATION SPECIFIC FOR THE SUBSTANCE OR MIXTURE
15.1.1. EU regulations
No particular information
15.1.2. National regulations
No particular information
15.1.3. Restrictions of occupation
No particular information
15.2. CHEMICAL SAFETY ASSESSMENT
No particular information
SECTION 16: OTHER INFORMATION
16.1. INDICATION OF CHANGES
Indication of changes:
16.2. ABBREVIATIONS AND ACRONYMS
LEGEND:
- ADR: European Agreement concerning the International Carriage of Dangerous Goods by Road
- CAS Number: Chemical Abstract Service Number
- EC Number: The identification number in the EC Inventory of Chemicals
- CLP: EC Regulation 2008/1272
- DNEL: Derived No Effect Level
- EmS: Emergency Schedule
- GHS: Global Harmonised System for the classification and labelling of chemical prosucts
- IATA DGR: Dangerous Goods Regulations for the transport of dangerous goods by the International Air Transport Association
- IC50: The Concentration 50% is a measure of the effectiveness of a substance in inhibiting a specific biological or biochemical function
- ICAO: echnical Instructions for the Safe Transport of Dangerous Goods by Air
- IMDG: International Maritime Dangerous Goods Code for the transportation or shipment of dangerous goods
- IMO: International Maritime Organization
- INDEX NUMBER: Identification number in the Annex VI of CLP
- LC50: Letal concentration 50%
- LD50: Letal dose 50%
- OEL: Occupational Exposure Level
- REACH : EC Regulation 2006/1907
- RID: Regulations concerning the International Carriage of Dangerous Goods by Rail
- VOC: Volatile Organic Compound
- vPvB: very Persistent and very Bioaccumulative (REACH)
AVENTI GI COMPLETE TABLETS
Code SLP2765
SAFETY DATA SHEET
Revision 1
Date of revision 31/03/2019
Page 9 / 9
16.3. KEY LITERATURE REFERENCES AND SOURCES FOR DATA
SOURCES:
- EU Regulation 2006/1907 (REACH)
- EU Regulation 2008/1272 (CLP)
- EU Regulation 2009/790 (I CLP Atp)
- EU Regulation 2011/286 (II CLP Atp)
- EU Regulation 2012/618 (III CLP Atp)
- EU Regulation 2013/487 (IV CLP Atp)
- EU Regulation 2013/944 (V CLP Atp)
- EU Regulation 2014/605 (VI CLP Atp)
- EU Regulation 2015/1221 (VII CLP Atp)
- EU Regulation 2015/830
- EU Regulation 2016/918 (VIII CLP Atp)
- EU Regulation 2016/1179 (IX CLP Atp)
- Web site of ECHA Agency
16.4. CLASSIFICATION FOR MIXTURES AND USED EVALUATION METHOD ACCORDING TO REGULATION (EC) 1272/2008 [CLP]
No particular information
16.5. RELEVANT H-, P- AND EUH-PHRASES (NUMBER AND FULL TEXT)
HAZARD STATEMENTS:
H413: May cause long lasting harmful effects to aquatic life.
PRECAUTIONARY STATEMENTS:
16.6. TRAINING ADVICE
No particular information
16.7. FURTHER INFORMATION
Note for users:
The information contained in the present document are based on our own knowledge on the date of its last version. Users must verify the
suitability and thoroughness of the information provided according to each specific use of the product. This document must not be regarded as
a guarantee on any specific product property. As the use of the product here referenced is not under our direct control, users must, under their
responsability, comply with the current health and safety laws and regulations. The producer is relieved from any liability arising from improper
use.
